Universe Pharmaceuticals holders report 4.9% stake

Universe Pharmaceuticals INC reported that Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz together beneficially own 28,111 ordinary shares, representing 4.9% of the company’s ordinary shares as of the event date.

Accepted by SEC EDGAR 01/07/2026 - 03:37 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Universe Pharmaceuticals INC reported that Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz together beneficially own 28,111 ordinary shares, representing 4.9% of the company’s ordinary shares as of the event date. All three reporting persons have no sole voting or dispositive power over these shares, but share voting and dispositive power for the full 28,111 shares. They certify that the securities were acquired and are held on a passive basis, not for the purpose of changing or influencing control of Universe Pharmaceuticals.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in UPC is reported in this Schedule 13G/A?

The reporting persons disclose beneficial ownership of 28,111 ordinary shares of Universe Pharmaceuticals INC, representing 4.9% of the outstanding ordinary shares.

Who are the reporting persons in this UPC Schedule 13G/A filing?

The reporting persons are Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz, each reporting beneficial ownership of the same 28,111 ordinary shares.

Do the UPC reporting persons have sole or shared voting power over the shares?

Each reporting person reports 0 shares with sole voting or dispositive power and 28,111 shares with shared voting and shared dispositive power.

Is the reported UPC stake above or below 5% of the class?

The reported ownership is 4.9% of the class, which is just under the 5% threshold often used for significant ownership reporting.

Are the UPC shares held to influence control of the company?

The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing the control of Universe Pharmaceuticals INC.

What is the class of UPC securities covered by this Schedule 13G/A?

The filing covers Ordinary Shares of Universe Pharmaceuticals INC, identified by CUSIP G9442G138.

When was the ownership position in UPC measured for this report?

The date of the event requiring the statement is listed as 12/31/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Universe Pharmaceuticals INC

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

G9442G138

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G9442G138

1

Names of Reporting Persons

SABBY MANAGEMENT, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 28,111.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 28,111.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

28,111.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. G9442G138

1

Names of Reporting Persons

SABBY VOLATILITY WARRANT MASTER FUND LTD

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 28,111.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 28,111.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

28,111.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. G9442G138

1

Names of Reporting Persons

HAL MINTZ

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

FLORIDA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 28,111.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 28,111.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

28,111.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Universe Pharmaceuticals INC
(b)	Address of issuer's principal executive offices: 265 JINGJIU AVENUE, 265 JINGJIU AVENUE, JI'AN, JIANGXI, CHINA, 343100.
Item 2.
(a)	Name of person filing: Sabby Volatility Warrant Master Fund, Ltd. Sabby Management, LLC Hal Mintz
(b)	Address or principal business office or, if none, residence: Sabby Volatility Warrant Master Fund, Ltd. c/o Captiva (Cayman) Ltd Governors Square, Bldg 4, 2nd Floor 23 Lime Tree Bay Avenue P.O. Box 32315 Grand Cayman KY1-1209 Cayman Islands Sabby Management, LLC 1011 Links Dr. Miami Beach, FL 33109 Hal Mintz c/o Sabby Management, LLC 1011 Links Dr. Miami Beach, FL 33109
(c)	Citizenship: Sabby Volatility Warrant Master Fund, Ltd. - Cayman Islands Sabby Management, LLC - Delaware, USA Hal Mintz - USA
(d)	Title of class of securities: Ordinary Shares
(e)	CUSIP No.: G9442G138
Item 4.	Ownership
(a)	Amount beneficially owned: Sabby Volatility Warrant Master Fund, Ltd. - 28,111 Sabby Management, LLC - 28,111 Hal Mintz - 28,111
(b)	Percent of class: Sabby Volatility Warrant Master Fund, Ltd. - 4.9% Sabby Management, LLC - 4.9% Hal Mintz - 4.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 28,111
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 28,111
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SABBY MANAGEMENT, LLC

Signature:	/s/ Robert Grundstein
Name/Title:	Chief Operating Officer
Date:	01/07/2026

SABBY VOLATILITY WARRANT MASTER FUND LTD

Signature:	/s/ Harry Thompson
Name/Title:	Authorized Person of TDF Management Ltd., a Director
Date:	01/07/2026

HAL MINTZ

Signature:	/s/ Hal Mintz
Name/Title:	Hal Mintz
Date:	01/07/2026